These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 4788038)

  • 1. Effects of suramin on complement, blood clotting, fibrinolysis and kinin formation.
    Eisen V; Loveday C
    Br J Pharmacol; 1973 Dec; 49(4):678-87. PubMed ID: 4788038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivity of alpha 1-antitrypsin mutants against proteolytic enzymes of the kallikrein-kinin, complement, and fibrinolytic systems.
    Patston PA; Roodi N; Schifferli JA; Bischoff R; Courtney M; Schapira M
    J Biol Chem; 1990 Jun; 265(18):10786-91. PubMed ID: 2191958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein.
    Harpel PC
    J Exp Med; 1970 Aug; 132(2):329-52. PubMed ID: 4101346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation.
    Schreiber AD; Kaplan AP; Austen KF
    J Clin Invest; 1973 Jun; 52(6):1402-9. PubMed ID: 4703226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of proteases in coagulation, kinin-forming and complement systems by alpha2-plasmin inhibitor.
    Moroi M; Aoki N
    J Biochem; 1977 Oct; 82(4):969-72. PubMed ID: 144728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in the kallikrein-kinin and complement system in angiography using non-ionic contrast media].
    Hoffmeister HM; Fuhrer G; Pirschel J; Heller W
    Klin Wochenschr; 1988 Sep; 66(17):760-3. PubMed ID: 3263537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the plasma clotting, fibrinolytic, and kinin-kallikrein system in preterm infants with severe idiopathic respiratory distress syndrome.
    Brus F; van Oeveren W; Okken A; Oetomo SB
    Pediatr Res; 1994 Nov; 36(5):647-53. PubMed ID: 7877886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation systems in contrast idiosyncrasy.
    Lasser EC; Hang JH; Hamblin AE; Lyon SG; Howard M
    Invest Radiol; 1980; 15(6 Suppl):S2-5. PubMed ID: 7203924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion.
    Wachtfogel YT; Kucich U; Hack CE; Gluszko P; Niewiarowski S; Colman RW; Edmunds LH
    J Thorac Cardiovasc Surg; 1993 Jul; 106(1):1-9; discussion 9-10. PubMed ID: 7686593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leucaena leucocephala serine proteinase inhibitor: primary structure and action on blood coagulation, kinin release and rat paw edema.
    Oliva ML; Souza-Pinto JC; Batista IF; Araujo MS; Silveira VF; Auerswald EA; Mentele R; Eckerskorn C; Sampaio MU; Sampaio CA
    Biochim Biophys Acta; 2000 Mar; 1477(1-2):64-74. PubMed ID: 10708849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kallikrein-kinin system and fibrinolysis in hereditary angioedema due to factor XII gene mutation Thr309Lys.
    Bork K; Kleist R; Hardt J; Witzke G
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):325-32. PubMed ID: 19474702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunochemical studies of plasma kallikrein.
    Bagdasarian A; Lahiri B; Talamo RC; Wong P; Colman RW
    J Clin Invest; 1974 Dec; 54(6):1444-54. PubMed ID: 4140197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New synthetic inhibitors of C1r, C1 esterase, thrombin, plasmin, kallikrein and trypsin.
    Fujii S; Hitomi Y
    Biochim Biophys Acta; 1981 Oct; 661(2):342-5. PubMed ID: 6271224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some proteins not belonging to the clotting or to the kallikrein-kinin system altered by kallikrein.
    Péjaudier L; Kichenin V; Audran R; Steinbuch M
    Hoppe Seylers Z Physiol Chem; 1983 Jun; 364(6):651-4. PubMed ID: 6224732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemical regulation of clotting, fibrinolysis and kinin formation in the blood by synthetic inhibitors of serine proteinases].
    Markwardt F; Klöcking HP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 97(1):95-103. PubMed ID: 4114589
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of oxytocin on fibrinolysis and the status of the kallikrein-kinin system].
    Kirichuk VF; Burova MB
    Probl Endokrinol (Mosk); 1989; 35(2):81-4. PubMed ID: 2740321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrinsic activation of plasma kinin formation and complement.
    Eisen V; Loveday C
    Int Arch Allergy Appl Immunol; 1973; 45(1):91-4. PubMed ID: 4199409
    [No Abstract]   [Full Text] [Related]  

  • 18. [The direct effect of pancreatic kallikrein (andecalin) on blood coagulation and fibrinolysis indices].
    Kiselev VI; Shakhmatov II
    Farmakol Toksikol; 1988; 51(2):63-6. PubMed ID: 3378609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separation of plasma thromboplastin antecedent from kallikrein by the plasma 2 -macroglobulin, kallikrein inhibitor.
    Harpel PC
    J Clin Invest; 1971 Oct; 50(10):2084-90. PubMed ID: 5165598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The "Hageman" connection: interrelationships of blood coagulation, fibrino(geno)lysis, kinin generation, and complement activation.
    Murano G
    Am J Hematol; 1978; 4(4):409-17. PubMed ID: 362910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.